NCT06472895 A Study of AK112 Monotherapy in Advanced/Metastatic Renal Cell Carcinoma Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT06424080 Oncological and Perioperative Outcomes of Laparoscopic Versus Robotic Partial Nephrectomy for Treatment of Renal Tumors. Status RECRUITING Phase NA
NCT06391879 Establishment of a Multidimensional Prediction Model for the Natural Course of VHL Disease-related Renal Cell Carcinoma Status RECRUITING Phase N/A
NCT06383507 A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors Status NOT_YET_RECRUITING Phase PHASE1
NCT06376669 Stereotactic Body Proton Therapy for Treatment of Primary Renal Cell Carcinoma Status RECRUITING Phase PHASE2
NCT06362369 A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy Status RECRUITING Phase PHASE1/PHASE2
NCT06342323 The Optimal Number of Fiducial Marker for Stereotactic Body Radiotherapy Status RECRUITING Phase N/A
NCT06336187 European Active Surveillance of Renal Cell Carcinoma Study (EASE RCC Study) Status RECRUITING Phase N/A
NCT06318871 Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT06317207 Evaluation of the Safety of Reoperation for Ipsilateral Recurrent Tumors After Nephron-sparing Partial Nephrectomy Status COMPLETED Phase N/A
NCT06307431 A Study of Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Renal Cell Carcinoma (V940-004). Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06299163 NM32-2668 in Adult Patients With Selected Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT06285097 A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT06265285 Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program Status RECRUITING Phase PHASE2
NCT06265025 GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06255223 A Study of Multimodal Radiotherapy for Renal Cell Carcinoma Progressed After Prior Immunotherapy Status RECRUITING Phase PHASE2
NCT06234605 A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma Status RECRUITING Phase PHASE1